미국의 헬스케어 분야 증강현실(AR) 및 가상현실(VR) 시장 규모, 점유율, 동향 분석 보고서 : 컴포넌트별, 기술 유형별, 부문 예측(2025-2030년)

Market Size & Trends:

The U.S. augmented reality and virtual reality in healthcare market size was estimated at USD 1.03 billion in 2024 and is projected to grow at a CAGR of 15.4% from 2025 to 2030. Advancements in healthcare IT infrastructure and increased venture capital investment, fueled by numerous start-ups and government programs such as NIH and FDA initiatives, support AR/VR research. In addition, the declining cost of head-mounted devices, rising demand from telemedicine, chronic disease care, and minimally invasive surgery, and integration with AI and 5G technologies for enhanced real-time diagnostics and clinical training.

AR and VR are crucial innovations in immersive technology. AR enhances real-world perception by directly integrating digital information, such as sounds, images, or text, into our real-world viewpoint. This facilitates interactive experiences, allowing for the visualization of complex concepts within a tangible context. VR offers a comprehensive immersion, transporting users to a simulated environment. This allows for interaction within a digital space, offering an experience entirely distinct from the real world. These technologies are instrumental in advancing user engagement and understanding in various sectors.

Virtual reality is revolutionizing medical education by offering immersive and interactive experiences that enhance knowledge retention and furnish environments for training devoid of risks. For instance, in March of 2023, Dr. Kei Ouchi, an Associate Professor of Medicine at Harvard Medical School and advisor of Jolly Good, collaborated with Brigham and Women's Hospital to create VR content designed for emergency care. Under the guidance and supervision of Dr. Ouchi, Jolly Good is expected to develop live-action VR content across various medical specialties, with a collaborative focus on evaluating its educational impact.

Similar to VR, AR is significantly transforming medical education. It allows students to examine anatomical structures and disease pathologies through an interactive, three-dimensional format. For instance, in June 2024, GE HealthCare and MediView XR successfully implemented the first-ever clinical use of the OmnifyXR Interventional Suite at a medical center in Minneapolis. This cutting-edge solution combines augmented reality with live imaging and 3D anatomical views, aiming to streamline radiology procedures and improve real-time collaboration.

The integration of Artificial Intelligence (AI) with Augmented Reality (AR) and Virtual Reality (VR) is transforming healthcare by enabling more accurate diagnostics, immersive medical training, and enhanced surgical planning. AI powers real-time data interpretation in AR/VR platforms, improving clinical decision-making and personalization of treatment. This convergence is gaining traction in education and healthcare alike, as seen in cross-industry partnerships. For instance, in August 2023, EON Reality, Inc. partnered with Sandals Corporate University (SCU) to introduce Spatial AI technology, utilizing AI-powered XR solutions to enhance learning and information retention through immersive experiences.

U.S. Augmented Reality And Virtual Reality In Healthcare Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. augmented reality and virtual reality market report on the basis of component and technology type

• Component Outlook (Revenue, USD Million, 2018 - 2030)
• Hardware
• Software
• Technology Type Outlook (Revenue, USD Million, 2018 - 2030)
• Augmented Reality
  • Surgical Application
  • Rehabilitation
  • Training & Continuing Medical Education
• Virtual Reality
  • Simulation
  • Diagnostics
  • Virtual Reality Exposure Therapy (VRET)
  • Rehabilitation
  • Pain Distraction

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Component
  • 1.2.2. Technology Type
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Adoption Of AR/VR in Surgical And Diagnostic Procedures
    • 3.2.1.2. Increase in telemedicine and remote patient monitoring
    • 3.2.1.3. Growing investments and increasing government support
    • 3.2.1.4. Increasing adoption of AR and VR applications in training and education
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Implementation Costs
    • 3.2.2.2. Data privacy and security concerns
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape
  • 3.3.3. Impact of COVID-19

Chapter 4. U.S. Augmented Reality And Virtual Reality In Healthcare Market: Component Estimates & Trend Analysis

• 4.1. Component Segment Dashboard
• 4.2. Component Market Share Movement Analysis, 2024 & 2030
• 4.3. Market Size & Forecasts and Trend Analysis, by Component, 2018 to 2030 (USD Million)
• 4.4. Hardware
  • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Software
  • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Augmented Reality And Virtual Reality In Healthcare Market: Technology Type Estimates & Trend Analysis

• 5.1. Technology Type Segment Dashboard
• 5.2. Technology Type Market Share Movement Analysis, 2024 & 2030
• 5.3. Market Size & Forecasts and Trend Analysis, by Technology Type, 2018 to 2030 (USD Million)
• 5.4. Augmented Reality
  • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.1.1. Surgical Application
      • 5.4.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.1.2. Rehabilitation
      • 5.4.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.1.3. Training & Continuing Medical Education
      • 5.4.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Virtual Reality
  • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.1.1. Simulation
      • 5.5.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.1.2. Diagnostics
      • 5.5.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.1.3. Virtual Reality Exposure Therapy (VRET)
      • 5.5.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.1.4. Rehabilitation
      • 5.5.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.1.5. Pain Distraction
      • 5.5.1.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position/Share Analysis, 2024
• 6.3. Company Categorization
• 6.4. Company Profiles/Listing
  • 6.4.1. Elevate Healthcare
    • 6.4.1.1. Overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Stryker
    • 6.4.2.1. Overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. EON Reality, Inc.
    • 6.4.3.1. Overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. Intuitive Surgical Operations, Inc.
    • 6.4.4.1. Overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. GE HealthCare
    • 6.4.5.1. Overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. Microsoft
    • 6.4.6.1. Overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. WorldViz, Inc.
    • 6.4.7.1. Overview
    • 6.4.7.2. Financial performance
    • 6.4.7.3. Product benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. Medscape (WebMD LLC)
    • 6.4.8.1. Overview
    • 6.4.8.2. Financial performance
    • 6.4.8.3. Product benchmarking
    • 6.4.8.4. Strategic initiatives
  • 6.4.9. Apple Inc.
    • 6.4.9.1. Overview
    • 6.4.9.2. Financial performance
    • 6.4.9.3. Product benchmarking
    • 6.4.9.4. Strategic initiatives
  • 6.4.10. CAE Healthcare Inc.
    • 6.4.10.1. Overview
    • 6.4.10.2. Financial performance
    • 6.4.10.3. Product benchmarking
    • 6.4.10.4. Strategic initiatives
  • 6.4.11. Hologic, Inc.
    • 6.4.11.1. Overview
    • 6.4.11.2. Financial performance
    • 6.4.11.3. Product benchmarking
    • 6.4.11.4. Strategic initiatives
  • 6.4.12. Siemens Healthineers
    • 6.4.12.1. Overview
    • 6.4.12.2. Financial performance
    • 6.4.12.3. Product benchmarking
    • 6.4.12.4. Strategic initiatives
  • 6.4.13. Koninklijke Philips N.V.
    • 6.4.13.1. Overview
    • 6.4.13.2. Financial performance
    • 6.4.13.3. Product benchmarking
    • 6.4.13.4. Strategic initiatives
  • 6.4.14. EchoPixel
    • 6.4.14.1. Overview
    • 6.4.14.2. Financial performance
    • 6.4.14.3. Product benchmarking
    • 6.4.14.4. Strategic initiatives
  • 6.4.15. Surgical Theater, Inc.
    • 6.4.15.1. Overview
    • 6.4.15.2. Financial performance
    • 6.4.15.3. Product benchmarking
    • 6.4.15.4. Strategic initiatives
  • 6.4.16. SAMSUNG
    • 6.4.16.1. Overview
    • 6.4.16.2. Financial performance
    • 6.4.16.3. Product benchmarking
    • 6.4.16.4. Strategic initiatives
  • 6.4.17. HTC Corporation
    • 6.4.17.1. Overview
    • 6.4.17.2. Financial performance
    • 6.4.17.3. Product benchmarking
    • 6.4.17.4. Strategic initiatives